We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
(+4.2%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$330M |
| 2 |
Brookdale Senior Living
BKD
|
+$93.7M |
| 3 |
Tenet Healthcare
THC
|
+$85.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$70.6M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$206M |
| 2 |
CVS Health
CVS
|
+$122M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$102M |
| 4 |
McKesson
MCK
|
+$80.6M |
| 5 |
Pacira BioSciences
PCRX
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.08% |
| 2 | Miscellaneous | 9.89% |
| 3 | Energy | 6.47% |
| 4 | Consumer Discretionary | 5.67% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Amgen
AMGN
$203B
| $256K | ﹤0.01% |
+2,160
| New | +$250K |
|
902
Arrow Electronics
ARW
$10.8B
| $256K | ﹤0.01% |
4,244
-2,532
| -37% | -$148K |
|
|
GRMN
903
Garmin
GRMN
$53.4B
| $256K | ﹤0.01% |
+4,198
| New | +$241K |
|
904
H&R Block
HRB
$5.56B
| $256K | ﹤0.01% |
+7,623
| New | +$227K |
|
905
Smith & Wesson
SWBI
$586M
| $256K | ﹤0.01% |
+22,925
| New | +$271K |
|
906
NCR Voyix
VYX
$982M
| $254K | ﹤0.01% |
11,803
-487
| -4% | -$9.84K |
|
|
FNSR
907
DELISTED
Finisar Corp
FNSR
| $253K | ﹤0.01% |
12,797
-10,999
| -46% | -$264K |
|
908
AB InBev
BUD
$157B
| $248K | ﹤0.01% |
+2,156
| New | +$237K |
|
909
Annaly Capital Management
NLY
$16B
| $247K | ﹤0.01% |
+5,413
| New | +$250K |
|
|
HSP
910
DELISTED
HOSPIRA INC
HSP
| $247K | ﹤0.01% |
4,800
-1,600
| -25% | -$75.9K |
|
911
Synopsys
SNPS
$72.5B
| $246K | ﹤0.01% |
6,346
+959
| +18% | +$36.6K |
|
|
WFM
912
DELISTED
Whole Foods Market Inc
WFM
| $246K | ﹤0.01% |
+6,360
| New | +$277K |
|
|
ESV
913
DELISTED
Ensco Rowan plc
ESV
| $245K | ﹤0.01% |
1,100
| – | – |
|
914
Cheniere Energy
LNG
$55.3B
| $244K | ﹤0.01% |
+3,402
| New | +$207K |
|
915
New York Times
NYT
$11.7B
| $242K | ﹤0.01% |
15,936
-7,157
| -31% | -$112K |
|
916
Bloomin' Brands
BLMN
$688M
| $241K | ﹤0.01% |
+10,752
| New | +$237K |
|
|
TIVO
917
DELISTED
Tivo Inc
TIVO
| $241K | ﹤0.01% |
10,075
-161
| -2% | -$3.73K |
|
|
WDR
918
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $240K | ﹤0.01% |
+3,838
| New | +$248K |
|
919
Cigna
CI
$74.1B
| $239K | ﹤0.01% |
2,600
-3,400
| -57% | -$292K |
|
|
PACW
920
DELISTED
PacWest Bancorp
PACW
| $239K | ﹤0.01% |
+5,531
| New | +$231K |
|
|
DST
921
DELISTED
DST Systems Inc.
DST
| $239K | ﹤0.01% |
5,182
-982
| -16% | -$45.2K |
|
922
Walt Disney
DIS
$185B
| $238K | ﹤0.01% |
2,779
-9,464
| -77% | -$773K |
|
923
Wabtec
WAB
$46.7B
| $238K | ﹤0.01% |
+2,877
| New | +$222K |
|
|
BRCD
924
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $238K | ﹤0.01% |
25,910
+3,997
| +18% | +$36.8K |
|
|
PLCM
925
DELISTED
POLYCOM INC
PLCM
| $238K | ﹤0.01% |
18,987
+8,026
| +73% | +$102K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Visium Asset Management deployed $227M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 56% a quarter earlier, followed by Miscellaneous and Energy.
On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.
- Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
- Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
- Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
- Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
- Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
- Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
- Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.
Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.